Suraksha Diagnostic's shares debuted with a slight discount on BSE and NSE, mirroring its low grey market premium. The IPO, entirely an offer for sale, saw modest oversubscription. The company, operating across eastern India, aims to capitalize on the growing diagnostics market, boasting increased revenue and profit in FY24.
